Inhibition of inducible nitric oxide synthase after myocardial ischemia increases coronary flow Patrick E Parrino, MD, Victor E Laubach, PhD, John R Gaughen, BA, Kimberly S Shockey, MS, Terri-Ann Wattsman, MD, Robert C King, MD, Curtis G Tribble, MD, Irving L Kron, MD The Annals of Thoracic Surgery Volume 66, Issue 3, Pages 733-739 (September 1998) DOI: 10.1016/S0003-4975(98)00605-5
Fig 1 Schematic of the isolated, blood-perfused heart circuit. (Vent = ventilator.) The Annals of Thoracic Surgery 1998 66, 733-739DOI: (10.1016/S0003-4975(98)00605-5)
Fig 2 Coronary flow during postintervention perfusion. (L-NAME = Nω-nitro-l-arginine methyl ester; LD 1400W = low-dose 1400W; HD 1400W = high-dose 1400W; Non I 1400W = nonischemic 1400W; Non I Control = nonischemic control.) The Annals of Thoracic Surgery 1998 66, 733-739DOI: (10.1016/S0003-4975(98)00605-5)
Fig 3 Left ventricular developed pressure during postintervention perfusion. (L-NAME = Nω-nitro-l-arginine methyl ester; LD 1400W = low-dose 1400W; HD 1400W = high-dose 1400W; Non I 1400W = nonischemic 1400W; Non I Control = nonischemic control.) The Annals of Thoracic Surgery 1998 66, 733-739DOI: (10.1016/S0003-4975(98)00605-5)